Engineered fluoride sensitivity enables biocontainment and selection of genetically-modified yeasts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33122649.
- Also identified by DOI 10.1038/s41467-020-19271-1 and PMC identifier 7596524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biocontainment systems are needed to neutralize genetically modified organisms (GMOs) that pose ecological threats outside of controlled environments. In contrast, benign selection markers complement GMOs with reduced fitness. Benign selection agents serve as alternatives to antibiotics, which are costly and risk spread of antibiotic resistance. Here, we present a yeast biocontainment strategy leveraging engineered fluoride sensitivity and DNA vectors enabling use of fluoride as a selection agent. The biocontainment system addresses the scarcity of platforms available for yeast despite their prevalent use in industry and academia. In the absence of fluoride, the biocontainment strain exhibits phenotypes nearly identical to those of the wildtype strain. Low fluoride concentrations severely inhibit biocontainment strain growth, which is restored upon introduction of fluoride-based vectors. The biocontainment strategy is stringent, easily implemented, and applicable to several eukaryotes. Further, the DNA vectors enable genetic engineering at reduced costs and eliminate risks of propagating antibiotic resistance.
Medical subject headings
- Fluorides
- Membrane Proteins
- Organisms, Genetically Modified
- Saccharomyces cerevisiae
- Saccharomyces cerevisiae Proteins
- Selection, Genetic